Market Overview:
The global transcranial magnetic stimulator market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of neurological disorders, rising awareness about the benefits of TMS therapy, and technological advancements in TMS devices. By type, the adult segment is expected to account for the majority share of the global transcranial magnetic stimulator market in 2018. By application, depression is expected to be the largest segment of the global transcranial magnetic stimulator market in 2018. Geographically, North America is estimated to account for a major share of this market in 2018.
Product Definition:
A transcranial magnetic stimulator (TMS) is a device that uses strong magnets to create electrical fields outside the head. These electrical fields can then be used to stimulate specific areas of the brain.
Adult:
The global adult (18 years and above) TMS market size was valued at USD 1.1 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of neurological disorders, such as stroke, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease among others are driving the demand for this device globally.
Children:
The global children and it's usage in transcranial magnetic stimulator market size was valued at USD 16.5 million in 2016 and is expected to grow at a CAGR of XX% over the forecast period.
Application Insights:
The others segment includes brain injury, epilepsy, migraine and Huntington's disease. The depression segment held the largest share of the global market in 2017 owing to its high prevalence rate. According to a study published in The Journal of Neuroscience in 2015, around 1 out of every 3 people suffer from depression during their lifetime. Thus, increasing awareness about this disorder is resulting into increased usage of tDCS for treating it which is boosting the demand for devices across the globe.
Tinnitus or hearing ringing sounds in ears is another major application where tDCS has been found useful as an alternative treatment option with fewer side effects as compared to drug therapies available till date. In June 2016, Focustech Ltd.
Regional Analysis:
North America dominated the global transcranial magnetic stimulator market in 2017. This can be attributed to rising government initiatives, increasing awareness about brain tumor treatment options, and availability of highly skilled physicians. In addition, presence of well-established healthcare facilities and favorable reimbursement policies are some other factors contributing toward the growth of this industry in North America.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to rising number of patients suffering from mental disorders such as depression or Alzheimer’s disease coupled with improving healthcare infrastructure in emerging countries such as India and China. Moreover, growing medical tourism industry due to low cost associated with treatment is also one factor driving growth in this region. For instance, according to a study published by The Lancet Global Health Journal on October 2016; India accounted for top three countries for medical tourism due its affordable treatments offered by world class hospitals there (Thelwall et al., 2016).
Growth Factors:
- Increasing demand for non-invasive brain stimulation therapies to treat various neurological disorders
- Growing awareness about the benefits of TMS therapy among healthcare professionals and patients
- Technological advancements in TMS devices and increasing R&D investments by manufacturers
- Rising number of clinical studies evaluating the efficacy of TMS therapy for various indications
- Growing number of treatment centers offering TMS therapy
Scope Of The Report
Report Attributes
Report Details
Report Title
Transcranial Magnetic Stimulator Market Research Report
By Type
Adult, Children
By Application
Depression, Tinnitus, Alzheimer’s, Obesity, Others
By Companies
Medtronic, Boston Scientific, Synapse Biomedical, Nevro Corporation, Neurosigma, Neuropace, Cyberonics, BioControl Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Transcranial Magnetic Stimulator Market Report Segments:
The global Transcranial Magnetic Stimulator market is segmented on the basis of:
Types
Adult, Children
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Depression, Tinnitus, Alzheimer’s, Obesity, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific
- Synapse Biomedical
- Nevro Corporation
- Neurosigma
- Neuropace
- Cyberonics
- BioControl Medical
Highlights of The Transcranial Magnetic Stimulator Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Adult
- Children
- By Application:
- Depression
- Tinnitus
- Alzheimer’s
- Obesity
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transcranial Magnetic Stimulator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A transcranial magnetic stimulator (TMS) is a medical device that uses magnets to stimulate specific areas of the brain. TMS is used to treat conditions such as depression, chronic pain, and migraines.
Some of the major companies in the transcranial magnetic stimulator market are Medtronic, Boston Scientific, Synapse Biomedical, Nevro Corporation, Neurosigma, Neuropace, Cyberonics, BioControl Medical.
The transcranial magnetic stimulator market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transcranial Magnetic Stimulator Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transcranial Magnetic Stimulator Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transcranial Magnetic Stimulator Market - Supply Chain
4.5. Global Transcranial Magnetic Stimulator Market Forecast
4.5.1. Transcranial Magnetic Stimulator Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transcranial Magnetic Stimulator Market Size (000 Units) and Y-o-Y Growth
4.5.3. Transcranial Magnetic Stimulator Market Absolute $ Opportunity
5. Global Transcranial Magnetic Stimulator Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Transcranial Magnetic Stimulator Market Size and Volume Forecast by Type
5.3.1. Adult
5.3.2. Children
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Transcranial Magnetic Stimulator Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Transcranial Magnetic Stimulator Market Size and Volume Forecast by Application
6.3.1. Depression
6.3.2. Tinnitus
6.3.3. Alzheimers
6.3.4. Obesity
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Transcranial Magnetic Stimulator Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Transcranial Magnetic Stimulator Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Transcranial Magnetic Stimulator Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Transcranial Magnetic Stimulator Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Transcranial Magnetic Stimulator Demand Share Forecast, 2019-2026
9. North America Transcranial Magnetic Stimulator Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Transcranial Magnetic Stimulator Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Transcranial Magnetic Stimulator Market Size and Volume Forecast by Application
9.4.1. Depression
9.4.2. Tinnitus
9.4.3. Alzheimers
9.4.4. Obesity
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Transcranial Magnetic Stimulator Market Size and Volume Forecast by Type
9.7.1. Adult
9.7.2. Children
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Transcranial Magnetic Stimulator Demand Share Forecast, 2019-2026
10. Latin America Transcranial Magnetic Stimulator Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Transcranial Magnetic Stimulator Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Transcranial Magnetic Stimulator Market Size and Volume Forecast by Application
10.4.1. Depression
10.4.2. Tinnitus
10.4.3. Alzheimers
10.4.4. Obesity
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Transcranial Magnetic Stimulator Market Size and Volume Forecast by Type
10.7.1. Adult
10.7.2. Children
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Transcranial Magnetic Stimulator Demand Share Forecast, 2019-2026
11. Europe Transcranial Magnetic Stimulator Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Transcranial Magnetic Stimulator Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Transcranial Magnetic Stimulator Market Size and Volume Forecast by Application
11.4.1. Depression
11.4.2. Tinnitus
11.4.3. Alzheimers
11.4.4. Obesity
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Transcranial Magnetic Stimulator Market Size and Volume Forecast by Type
11.7.1. Adult
11.7.2. Children
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Transcranial Magnetic Stimulator Demand Share, 2019-2026
12. Asia Pacific Transcranial Magnetic Stimulator Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Transcranial Magnetic Stimulator Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Transcranial Magnetic Stimulator Market Size and Volume Forecast by Application
12.4.1. Depression
12.4.2. Tinnitus
12.4.3. Alzheimers
12.4.4. Obesity
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Transcranial Magnetic Stimulator Market Size and Volume Forecast by Type
12.7.1. Adult
12.7.2. Children
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Transcranial Magnetic Stimulator Demand Share, 2019-2026
13. Middle East & Africa Transcranial Magnetic Stimulator Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Transcranial Magnetic Stimulator Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Transcranial Magnetic Stimulator Market Size and Volume Forecast by Application
13.4.1. Depression
13.4.2. Tinnitus
13.4.3. Alzheimers
13.4.4. Obesity
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Transcranial Magnetic Stimulator Market Size and Volume Forecast by Type
13.7.1. Adult
13.7.2. Children
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Transcranial Magnetic Stimulator Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Transcranial Magnetic Stimulator Market: Market Share Analysis
14.2. Transcranial Magnetic Stimulator Distributors and Customers
14.3. Transcranial Magnetic Stimulator Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Synapse Biomedical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Nevro Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Neurosigma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Neuropace
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Cyberonics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. BioControl Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
